Evidence map›Paper›PMID 38625419›Full record

ArticleDiscover oncology2024

Prediction of prostate cancer aggressiveness using magnetic resonance imaging radiomics: a dual-center study.

Nini Pan, Liuyan Shi, Diliang He, Jianxin Zhao, Lianqiu Xiong, Lili Ma, Jing Li, Kai Ai, Lianping Zhao, Gang Huang

Open access · goldAbstract read
In one paragraph

Article in Discover oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. [Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Nini PanThe First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu, China.
Liuyan ShiThe First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu, China.
Diliang HeThe First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu, China.
Jianxin ZhaoThe First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu, China.
Lianqiu XiongThe First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu, China.
Lili MaThe First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu, China.
Jing LiThe First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu, China.
Kai AiClinical and Technical Support, Philips Healthcare, Xi'an, China.
Lianping ZhaoDepartment of Radiology, Gansu Provincial Hospital, Lanzhou, 730000, Gansu, China.
Gang HuangDepartment of Radiology, Gansu Provincial Hospital, Lanzhou, 730000, Gansu, China. keen0999@163.com.ORCID http://orcid.org/0000-0001-6057-5349
Gansu University of Traditional Chinese Medicine · CNGansu Provincial Hospital · CNPhilips (China) · CN

Funding

the Beijing Medical Award Foundation YXJL-2022-0665-0197the grant from the Gansu Provincial Hospital 22GSSYD-33
6 · The paper itself

Abstract

purposeThe Gleason score (GS) and positive needles are crucial aggressive indicators of prostate cancer (PCa). This study aimed to investigate the usefulness of magnetic resonance imaging (MRI) radiomics models in predicting GS and positive needles of systematic biopsy in PCa. MATERIAL AND

methodsA total of 218 patients with pathologically proven PCa were retrospectively recruited from 2 centers. Small-field-of-view high-resolution T2-weighted imaging and post-contrast delayed sequences were selected to extract radiomics features. Then, analysis of variance and recursive feature elimination were applied to remove redundant features. Radiomics models for predicting GS and positive needles were constructed based on MRI and various classifiers, including support vector machine, linear discriminant analysis, logistic regression (LR), and LR using the least absolute shrinkage and selection operator. The models were evaluated with the area under the curve (AUC) of the receiver-operating characteristic.

resultsThe 11 features were chosen as the primary feature subset for the GS prediction, whereas the 5 features were chosen for positive needle prediction. LR was chosen as classifier to construct the radiomics models. For GS prediction, the AUC of the radiomics models was 0.811, 0.814, and 0.717 in the training, internal validation, and external validation sets, respectively. For positive needle prediction, the AUC was 0.806, 0.811, and 0.791 in the training, internal validation, and external validation sets, respectively.

conclusionsMRI radiomics models are suitable for predicting GS and positive needles of systematic biopsy in PCa. The models can be used to identify aggressive PCa using a noninvasive, repeatable, and accurate diagnostic method.

Indexed as

AggressivenessGleason scoreMagnetic resonance imagingPositive needlesProstate cancerRadiomics

Identifiers

PMID38625419
PMCPMC11019191
OpenAlexW4394850266

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.